Drug intelligence / Profile preview

betamethasone sodium phosphate + betamethasone acetate (Organon & Co.)

Development stage
Unknown
Lead developer
Organon
Modality
Small Molecules
Administration
Intramuscular
01

Overview

Celestone Chronodose is an injectable corticosteroid formulation consisting of a mixture of betamethasone sodium phosphate and betamethasone acetate. As a synthetic glucocorticoid, betamethasone acts as a potent agonist of the glucocorticoid receptor, leading to significant anti-inflammatory and immunosuppressive effects. The formulation is designed for dual-action: the highly soluble sodium phosphate component provides a rapid onset of action, while the less soluble acetate component provides sustained release for prolonged therapeutic activity. It is indicated for a wide range of inflammatory and allergic conditions, including asthma, arthritis, and severe dermatological disorders. Notably, it is used in obstetric care for the antepartum prevention of neonatal respiratory distress syndrome (RDS) in infants at risk of preterm birth, where it stimulates the production of lung surfactant.

Brand names
Celestone ChronodoseCelestone Soluspan
Other names
betamethasone sodium phosphate and betamethasone acetate
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on betamethasone sodium phosphate + betamethasone acetate (Organon & Co.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on betamethasone sodium phosphate + betamethasone acetate (Organon & Co.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call